The results showed that the combination of apatinib and CQ sensitized ESCC cells to paclitaxel to induce apoptosis through the IRE-1α–AKT–mTOR signaling pathway both in vivo and in vitro. The gene discussed is AKT1; the disease is esophageal squamous cell carcinoma.